Company: BLRX
Filing Date: 2025-01-07
Form Type: 424B5
Source: 0001178913-25-000045
Chunk: 8

Company: BioLineRx Ltd.
Filing Date: 2025-01-07
Form: 424B5
Chunk 8
---
 ADSs, representing 235,018,170 of our ordinary shares. The purchase price of each pre-funded warrant is $0.1999. The                                                              
 pre-funded warrants have an exercise price of $0.0001 per ADS, are immediately exercisable (subject to the beneficial ownership limitation) and may be exercised at any time until all of the pre-funded warrants are exercised in full. We are    
 also registering pursuant to this prospectus supplement and the accompanying prospectus the ADSs representing ordinary shares issuable from time to time upon the exercise of the pre-funded warrants in this offering. We do not intend to apply  
 for listing of the pre-funded warrants on the Nasdaq or any other securities exchange or nationally recognized trading system. See “Description of Securities We Are Offering” for more information.                                               |
| Warrants offered by us                                      |     | For each ADS or pre-funded warrant purchased in this offering, each investor will receive a warrant to purchase one ADSs (or a total of warrants to purchase up to an aggregate of 50,000,000                                                      
 ADSs, representing up to 750,000,000 ordinary shares). The warrants have an exercise price of $0.20 per ADS, are immediately exercisable from the date of issuance and will expire five years from the date of issuance. We are also registering   
 pursuant to this prospectus supplement and the accompanying prospectus the ADSs representing ordinary shares issuable from time to time upon the exercise of the warrants in this offering. We do not intend to apply for listing of the warrants  
 on the Nasdaq or any other securities exchange or nationally recognized trading system. See “Description of Securities We Are Offering” for more information.                                                                                      |
| Pre-Funded Warrants and Warrants exercise limitations       |     | The pre-funded warrants and warrants may not be exercised if the aggregate number of ordinary shares (including ADSs representing ordinary shares) beneficially owned by the holder thereof                                                        
 (together with its affiliates, and any persons acting as a group together with such holder or any of such holder’s affiliates or any other persons whose beneficial ownership of ADSs or ordinary shares would be aggregated with the holder’s or  
 any of the holder’s affiliates) would exceed 4.99% (or, at the election of the holder, 9.99%) immediately after exercise thereof.                                                                                                                  |
| Offering Price                                              |     | $0.20 per ADS and accompanying warrant and $0.1999 per pre-funded warrant and accompanying warrant.